Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease: Past, present, and future

Steven Naymagon, Thomas A. Ullman

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


The evidence supporting the practice of dysplasia surveillance in inflammatory bowel disease (IBD) has remained sparse, and optimal detection strategies are still lacking. These issues, added to the declining incidence of dysplasia in IBD, have led to much debate over the diagnosis and management of dysplasia. White-light endoscopy with targeted and random biopsies remains the technique of choice for most practicing gastroenterologists. However, during the past decade, a surge of literature has questioned the efficacy of this strategy. Simultaneously, chromoendoscopy has emerged as an alternative, and perhaps superior, technique that has been included in some society guidelines. Nevertheless, many issues remain unclear, such as the best way to implement chromoendoscopy into everyday practice, whether there are any outcome benefits that can be attributed to the use of chromoendoscopy, and, perhaps most importantly, how to manage dysplasia uncovered by this and other advanced techniques. In this article, we discuss the various techniques currently available for dysplasia surveillance in IBD, with a focus on chromoendoscopy. Additionally, we highlight the overarching issues of setting appropriate endpoints and individualizing the care of patients with long-standing colitis.

Original languageEnglish
Pages (from-to)304-311
Number of pages8
JournalGastroenterology and Hepatology
Issue number5
StatePublished - 1 May 2015


  • Chromoendoscopy
  • Crohn's disease
  • Dysplasia
  • Inflammatory bowel disease
  • Ulcerative colitis


Dive into the research topics of 'Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease: Past, present, and future'. Together they form a unique fingerprint.

Cite this